Susan Langer is the founder of Kojin Therapeutics. Kojin Therapeutics has raised $60M in total funding. Latest round: Series A.
Susan Langer was the acting president of Kojin Therapeutics, a Boston-based biotech company focused on developing therapies based on cell state and ferroptosis biology, with an initial focus on oncology. The company raised a $60 million Series A funding round in June 2021. Prior to Kojin Therapeutics, Langer was the Head of Corporate Strategy at Biogen.
Full founder directory · Investor directory · Company funding database · Fundraising library